VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com February 4th

Rhea-AI Summary

VolitionRx Limited (NYSE AMERICAN: VNRX) will be presenting live at VirtualInvestorConferences.com on February 4, 2021, at 12:00 PM EST. The session, led by Scott Powell, CFO, aims to engage investors with real-time Q&A opportunities. VolitionRx specializes in epigenetic blood tests to aid in diagnosing various cancers and diseases, utilizing Nucleosomics technology. Participants are encouraged to pre-register and check their systems to ensure smooth access. An archived version will be available post-event for those unable to attend live.

AUSTIN, Texas, Feb. 1, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present live at VirtualInvestorConferences.com on February 4^th.   

DATE: February 4^th, 2021
TIME: 12:00 PM EST
LINK: https://bit.ly/3brvZ8w

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

About VolitionRx Limited

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics^TM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.

Volition's research and development activities are centered in Belgium, with a small laboratory in California and additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

For more information about Volition, visit Volition's website volition.com or connect with us via:
Twitter: https://twitter.com/volitionrx  
LinkedIn: https://www.linkedin.com/company/volitionrx
Facebook: https://www.facebook.com/VolitionRx/

The contents found at Volition's website address, Twitter, LinkedIn, Facebook, and YouTube are not incorporated by reference into this document and should not be considered part of this document. The addresses for Volition's website, Twitter, LinkedIn, Facebook, and YouTube are included in this document as inactive textual references only.

About Virtual Investor Conferences^®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/volitionrx-limited-to-webcast-live-at-virtualinvestorconferencescom-february-4th-301219352.html

SOURCE VirtualInvestorConferences.com

FAQ

When is VolitionRx's presentation at VirtualInvestorConferences.com?

VolitionRx will present on February 4, 2021, at 12:00 PM EST.

Who is presenting for VolitionRx at the investor conference?

Scott Powell, EVP of Investor Relations and CFO of Volition America Inc., will present.

How can I participate in VolitionRx's live event?

Investors can participate by pre-registering and checking their online system before the event.

Is there a recording of the VolitionRx event available?

Yes, an archived webcast will be available for those who cannot attend the live presentation.

What type of tests does VolitionRx develop?

VolitionRx develops blood tests for diagnosing cancers and other diseases, focusing on early detection.

What is the stock symbol for VolitionRx?

The stock symbol for VolitionRx is VNRX.